Matthew A. Spear - 17 Jun 2021 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Johanna Mylet, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
+$6,610
Form type
4
Filing time
21 Jun 2021, 20:02:39 UTC
Previous filing
14 Jun 2021
Next filing
30 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Options Exercise $6,610 +5,000 +30% $1.32 21,485 17 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Options Exercise $0 -5,000 -4.2% $0.000000 114,861 17 Jun 2021 Common Stock 5,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.